The Association of High Sensitivity C-reactive protein and Nitric Oxide with Elevated Blood Pressure during Dialysis in Intradialytic Hypertension
DOI:
https://doi.org/10.3889/oamjms.2023.11377Keywords:
Intradialytic hypertension, hemodialysis, chronic kidney disease, hs-CRP, Nitric OxideAbstract
BACKGROUND: Hemodialysis (HD) is a procedure to replace part of kidney function in patients with end-stage kidney disease. Hemodynamic disturbances during HD may include elevated blood pressure (BP). It is reported that about 5–15% of patients undergoing regular HD have increased BP during HD. This condition is called intradialytic hypertension (IDH). Increased high sensitivity C-reactive protein (hs-CRP) levels are associated with decreased endothelial dilatation response of blood vessels. Nitric Oxide (NO) is one of the mediators that act as a vasodilator to regulate vascular pressure. Endothelial dysfunction is one of the factors thought to contribute to the incidence of IDH.
AIM: This study aimed to determine the association of hs-CRP and NO with elevated BP in IDH.
METHODS: This observational cross-sectional study was conducted at Prof. Dr. R.D. Kandou General Hospital, Manado, from November 2021 to April 2022. Participants were selected through consecutive sampling methods. The levels of hs-CRP and NO were examined in all patients. The correlation between hs-CRP and NO was performed using the Spearman test, while the association of hs-CRP and NO with elevated BP was performed using the Fisher- exact test or Chi-square test.
RESULTS: Forty patients were included in this study. The median hs-CRP, NO, and systolic BP (SBP) of the patients were 6.55 mg/dL (0.50–43.5), 27.77 mg/dL (3.65–72.19), and 20 mmHg (10–30), respectively. The correlation analysis showed that there was a strong significant negative correlation between hs-CRP levels and NO (r = −0.680, p = 0.000). Based on the Chi-Square or Fisher Exact test, there was a significant association between hs-CRP levels and elevated SBP (OR = 5.06; 95% CI = 1.095–23.44; p = 0.040), as well as between NO levels and elevated SBP (OR = 17.14; 95% CI = 3.063–95.938; p = 0.000).
CONCLUSION: There was a significant association between hs-CRP and NO levels with elevated SBP in end-stage renal disease (ESRD) patients with IDH. ESRD on hemodialysis (ESRD on R-HD) patients with hs-CRP ≤3 mg/dL or NO levels <25 mg/dL tends to have increased SBP ≥20 mmHg after HD compared to ESRD patients with low hs-CRP or high NO levels.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
I. Sudoyo A. Setiyohadi 8, AJwi I. Setiati S. Chronic kidney disease. In: Handbook of Internal Medicine. 6'" edition. Jakarta: International Publishing; 2014. p. 2159-65.
KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Off J lnt Soc Nephofrol. 2013:3(1) 19-62.
Indonesian Nephrology Association. Indonesian renal registry program. In: 1fh Report of Indonesian Renal Registry Jakarta: Pernefri Indonesian Nephrology Association: 2018. p. 1-46.
Hajal J, Saliba Y, Joubran N, Sleilaty G, Chacra D, Assaad S, et al. New insights into the pathogenesis of intradialytic hypertension. Open Urol Nephrol J. 2018;11(1):87-99. https://doi.org/10.217 411874303X01811010087
Agarwal R, Light RP. lntradialytic hypertension is a marker of volume excess. Nephrol Dial Transplant. 2010;25(10):3355-61. https://doi.org/10.1093/ndtlgfq210 PMid:20400448
Agarwal R, Metiku T, Tegegne GG, Light RP, Bunaye Z. Bekele DM, eta!. Diagnosing hypertension by intradialytic blood pressure recordings. Clin JAm Soc Nephrol. 2008;3(5):1364-72. https://doi.org/10.2215/CJN.01510308 PMid 18495949
Flythe JE, Chang Tl, Gallagher MP. Lindley E, Madero M, Sarafidis PA. eta!. Blood pressure and volume management in dialysis: Conclusions from a kidney Disease: Improving global outcomes {KDIGO) Controversies conference. Kidney Int. 2020:97(5) 861-76. https://doi.org/10.1016/kint202001.046 PMid 32278617
Liu HH, Cao YX, Sun D, Jin JL, Zhang HW, Guo YL, eta/. High sensitivity c-reactive protein and hypertension: Combined effects on coronary severity and cardiovascular outcomes. Hypertens Res. 2019:42:1783-93. https://doi.org/10.1038/541440-019-0293-8 PMid:31235846
Nongnuch A, Campbell N, stern E. EI-Kateb S, Fuentes L. Davenport A. Increased postdialysis systolic blood pressure is associated with extracellular overhydration in hemodialysis outpatients. Kidney Int. 2015;87(2):452-7. https://doi.org/10.1038/ki.2014.276 PMid:25075771
Carrero JJ, Franko MA. Obergfell A, Gabrielsen A. Jernberg T.
High-sensitivity C-reactive level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: A healthcare-based study. J Am Heart Assoc. 2019:8(11):e012638. https://doi.org/10.1161/JAHA119.012638 PMid 31140334
Aflyatumova GN, Nigmatullina RR, Sadykova Dl, Chibireva MD, Fugetto F, Serra R. Endothelin-1. nitric oxide. serotonin and high blood pressure in male adolescents. Vase Health Risk Manag. 2018;14:213-23. https://doi.org/10.2147NHRM.S170317 PMid 30271160
Labarcon KA. Bad-ang MT. Predictors of intradialytic hypertension in chronic end stage renal dialysis patients in a tertiary government hospital in Davao city. J Clin Nephrol Ther. 2018:1(1) 15-27.
Chandrashekara S. An inflammatory marker with specific role in physiology, pathology, and diagnosis. lnt J Rheumatol Clin lmmunol. 2014:2(S1)SR3.
Kalender B. Malnutrition in Chronic Kidney Disease and Association to Quality of Life. New York: Springer; 2010. p. 3160-9.
Wetmore JB. Lovett DH. Hung AM. Cook-Wiens G, Mahnken JD, Sen S, et al. Associations of interleukin-6. C-reactive protein and serum amyloid A with mortality in haemodialysis patients. Nephrology (Carlton). 2008;13(7):593-600. https/ldoi. org/10.1111/j.1440-1797.2008.01021.x PMid 18826487
Fliser D. Kielstein J. Hailer H, Bode-BoGer S. Asymemetric dimethylarginine: A cardiovascular risk factor in renal disease? Kidney lnt Suppl. 2003:84:S37-40. https://doi.org/10.1046/j.1523-1755.63.s84.11.x PMid 12694305
Chou KJ, Lee PT, Chen CL, Chiou CW, Hsu CY, Chung HM, et al. Physiological changes during hemodialysis in patients vvith intradialysis hypertension. Kidney Int. 2006;69(10):1833-8. https://doi.org/10.1038/sj.ki.5000266 PMid:16691262
Antosova M. Plevkova J, Strapkova A, Buday T. Nitric oxideimportant messenger in human body. Open J Mollntegr Physiol. 2012;2:98-106. https://doi.org/10.4236/ojmip.2012.23014
Dolly lA. The association between High Sensitive C-Reactive Protein (hs-CRP) and nitric oxide in the patients with hypertension. Media Med Muda. 2019:3(1):1-6.
Horiuchi M. Mogi M. C-reactive protein beyond biomarker of inflammation in metabolic syndrome. Hypertension. 2011:57( 4):672-73. https://doi.org/10.1161/HYPERTENSIONAHA 110.165845
Smith DA, Germolec DR. Introduction to immunology and autoimmunity. Environ Health Perspect. 1999:107(Suppl5):661-5. https://doi.org/10.1289/ehp.99107s5661 PMid:10502528
Tsuda K. Associations between high-sensitivity C-reactive protein and membrane fluidity of red blood cells in hypertensive elderly men: An electron spin resonance study. lnt J Hypertens. 2012;2012:292803. https://doi.org/10.1155/2012/292803 PMid:22518282
Jalali MJ, Phadke MS. Assessment of endothelial dysfunction in health and disease: Using various parameters. Indian J Clin Biochem. 2011:26(4):407-12. https//doi.org/10.1007/512291-011-0140-4 PMid:23024479
Inrig JK, Van Buren P. Kim C, Vongpatanasin W, Povsic TJ, Toto RD. lntradialytic hypertension and its association with endothelial cell dysfunction. Clin J Am Soc Nephrol. 2011;6(8) 2016-24. https//doi.org/10.2215/CJN.11351210 PMid 21757643
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Stella Palar, Cerelia Sugeng, Octavianus Umboh, Fandy Gosal, Cynthia Natalia (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
